2020
DOI: 10.1002/ps.5946
|View full text |Cite
|
Sign up to set email alerts
|

Sensitivity of Pythium spp. and Phytopythium spp. and tolerance mechanism of Pythium spp. to oxathiapiprolin

Abstract: BACKGROUND: Oxathiapiprolin, developed by DuPont, is the only commercial oxysterol-binding protein inhibitor (OSBPI) of oomycete pathogens. Although the activity of oxathiapiprolin on some Pythium spp. and Phytopythium spp. has been reported, it has not been tested on many other species, and little is known about the mechanisms of Pythium spp. that are tolerant to it. RESULTS: Oxathiapiprolin exhibited a strong inhibitory effect on mycelial growth of Phy. litorale, Phy. helicoides and Phy. chamaehyphon, with E… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 31 publications
0
6
0
Order By: Relevance
“…It is worth noting that the other three fungicides (i.e., mandipropamid, oxathiapiproline, and dimethomorph) are effective against the oomycetes, primarily Phytophthora and Pseudoperonospora species ( 15 , 27 ). However, we found these chemicals failed to markedly inhibit P. insidiosum , which is not a surprise since they also reportedly fail to control other Pythium species ( 61 , 62 ), underlying the biological diversity among closely related oomycetes.…”
Section: Discussionmentioning
confidence: 59%
“…It is worth noting that the other three fungicides (i.e., mandipropamid, oxathiapiproline, and dimethomorph) are effective against the oomycetes, primarily Phytophthora and Pseudoperonospora species ( 15 , 27 ). However, we found these chemicals failed to markedly inhibit P. insidiosum , which is not a surprise since they also reportedly fail to control other Pythium species ( 61 , 62 ), underlying the biological diversity among closely related oomycetes.…”
Section: Discussionmentioning
confidence: 59%
“…Notably, only a few drugs and one cyclic antifungal peptide from marine fungi have shown inhibitory effects against soybean phytophthora blight [ 21 , 22 , 23 , 24 ]. Interestingly, Fluoxapiprolin, Oxzthiapiprolin, and Ethaboxam, developed by Bayer and DuPont (Wilmington, DE, USA), have demonstrated the ability to inhibit the growth of P. sojae by targeting spores and mycelium ( Figure 1 ) [ 25 , 26 , 27 , 28 ]. However, it is worth noting that these compounds belong to the thiazole class, and mutations in the single dominant genes (Rps) and β-tubulin have been identified as potential causes of drug resistance [ 29 ].…”
Section: Introductionmentioning
confidence: 99%
“…16 Oxathiapiprolin exhibits extremely high activity against plant oomycete pathogens. [15][16][17][18][19] Recently, oxathiapiprolin was registered for the control of Phytophthora infestans, Phytophthora capsici, Pseudoperonospora cubensis, and Plasmopara viticola in China. However, no data are available on the baseline sensitivity or action mechanism of oxathiapiprolin against Phytophthora sojae, or on its efficacy for controlling soybean PRR.…”
Section: Introductionmentioning
confidence: 99%
“…Oxathiapiprolin [Fungicide Resistance Action Committee (FRAC) code 49] is a new piperidinyl thiazole isoxazoline fungicide developed by Dupont Crop Protection 15 and commercialized by Corteva Agriscience 16 . Oxathiapiprolin exhibits extremely high activity against plant oomycete pathogens 15–19 . Recently, oxathiapiprolin was registered for the control of Phytophthora infestans , Phytophthora capsici , Pseudoperonospora cubensis , and Plasmopara viticola in China.…”
Section: Introductionmentioning
confidence: 99%